CYBB and atherosclerosis: Production of ROS by NOX2 in inflammatory cells is an essential part of innate host defenses [1], but its absence can protect from inflammatory diseases such as atherosclerosis [2,3] and TBI [4], suggesting that NOX2 may be an attractive druggable target for these diseases [5].